RxDoctor Payments DataLook up a doctor →

Christopher Karcher, MD

Sleep Medicine · Ocean Springs, MSNPI 1194810408

Payments from drug & device makers

$25,906in general payments, 2019–2025

Across 1,487 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • UCB, Inc.$2K
  • Acadia Pharmaceuticals Inc$2K
  • Amgen$2K
  • Novartis$2K
  • AstraZeneca$1K
  • plus $14K from 52 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)240$3,295
UCB, Inc.116$2,114
Acadia Pharmaceuticals Inc107$1,893
Amgen(2 entities)84$1,801
Novartis101$1,666
AstraZeneca(2 entities)67$1,282
SK Life Science, Inc.64$1,277
Teva Pharmaceuticals USA, Inc.79$1,187
Genentech USA, Inc.52$1,169
Pfizer64$890
Lundbeck LLC37$779
Biogen44$725
Sunovion Pharmaceuticals Inc.32$585
Eisai Inc.26$533
EMD Serono, Inc.28$491
Bristol Myers Squibb25$464
Neurocrine Biosciences, Inc.23$459
Inspire Medical Systems, Inc.12$416
Sanofi22$404
Argenx US, Inc.19$383
Lilly USA, LLC22$334
Supernus Pharmaceuticals, Inc.32$329
Microtransponder, Inc.2$246
Adamas Pharmaceuticals, Inc.14$234
Johnson & Johnson(2 entities)16$196
CSL Behring10$194
Arbor Pharmaceuticals, Inc.14$187
ANI Pharmaceuticals, Inc.9$170
Takeda Pharmaceuticals U.S.A., Inc.7$165
Biohaven Pharmaceutical Holding Company Ltd.11$164
Harmony Biosciences LLC10$158
Mallinckrodt Hospital Products Inc.9$149
Jazz Pharmaceuticals Inc.8$146
Avanir Pharmaceuticals, Inc.8$117
Merz Pharmaceuticals, LLC6$115
Neurelis, Inc.6$112
GE HealthCare7$107
Vanda Pharmaceuticals Inc.5$104
Upsher-smith Laboratories LLC6$103
TG Therapeutics, Inc.6$102
MDD US Operations, LLC6$88
Philips North America LLC1$74
Tanabe Pharma America, Inc.5$72
Amylyx Pharmaceuticals, Inc.3$61
Amneal Pharmaceuticals LLC4$60
Axsome Therapeutics, Inc.2$37
Revance Therapeutics, Inc.2$37
Apria Healthcare LLC2$35
Alnylam Pharmaceuticals Inc.2$34
Kyowa Kirin, Inc.1$24
Acorda Therapeutics, Inc2$23
Life Molecular Imaging Ltd1$23
Boston Scientific1$18
Collegium Pharmaceutical, Inc.1$18
Banner Life Sciences, LLC1$16
Portola Pharmaceuticals, LLC1$16
Otsuka America Pharmaceutical, Inc.1$13
Azurity Pharmaceuticals, Inc.1$13

How this compares

Too few sleep medicine providers in Mississippito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$114,702
Medicare patients
653
Services billed
1,088

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sleep medicine in Ocean Springs

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →